Trading status Status de
  • Prices realtime
    • Indizes
      • Germany 40
      • MID Germany 50
      • TEC Germany 30
      • USA 30
      • EUROPE 50
      • TEC USA 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 14528
  • 14529
  • 14530
  • …
  • ›
  • »

2024-10-01

Notification on the disposal of voting rights

2024-10-01

Evoke Pharma announces proceeds from existing warrants and board expansion

2024-10-01

Form 8.3 - Keywords Studios Plc

2024-10-01

Basin Uranium Receives South Pass Project Approval

2024-10-01

Color Star Technology Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

2024-10-01

Laxxon Medical and Adare Pharma Solutions Announce Joint Cooperation for Production of cGMP 3D Printed Oral Dosage Forms in Europe and US

2024-10-01

Sify Technologies Ltd. Announces ADS Ratio Change to Be Effective on October 4, 2024

2024-10-01

Granite Real Estate Investment Trust and Granite REIT Inc. Complete Unwind of Stapled Unit Structure

2024-10-01

Wellfield Technologies Inc.: Wellfield Announces Spin-Off Initiatives and Trade Resumption

2024-10-01

Gear Energy Ltd. declares CAD 0.005 dividend

2024-10-01

Jaguar Health, Inc.: Jaguar Health Reports Statistically Significant Improvement in Breast Cancer Patients in its Phase 3 OnTarget Trial for its Cancer Supportive Care Drug Crofelemer

2024-10-01

IN8bio dips 9%, prices $12.4M private placement

  • «
  • ‹
  • …
  • 14528
  • 14529
  • 14530
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Realtimeprices 13/Aug/2026 11:28:57
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies